Post hoc analysis of SYNAPSE in 407 adults with CRSwNP: mepolizumab vs placebo improved polyp score, symptom VAS and SNOT-22 whether patients had 1 or >1 prior surgery; reduced risk of repeat surgery and oral steroid use was seen only after 1 prior surgery.
Secondary analysisn = 407
Han et al. Mepolizumab improves outcomes in patients with CRSwNP with one or more prior nasal polyp surgeries